XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended Jun...(as of June 30 2007 and 2006 ...)

(unaudited), and December 31, 2006 (audited)

(in thousands of US dollars, except share amounts)

June 30, December 31,

2007 2006 2006

---------- ---------- ----------

A s s e t s

CURRENT ASSETS:

Cash and cash equivalents 2,451 32,172 4,400

Short-term bank deposits 10,185 -- 20,845

Trading securities -- -- 102

Property and equipment

(held for sale) -- net 35 43 18

Deferred tax asset -- -- 29

Other receivables and prepaid expenses 651 644 702

--------- --------- ---------

Total current assets 13,322 32,859 26,096

--------- --------- ---------

EMPLOYEE SEVERANCE PAY FUNDS 42 173 98

RESTRICTED LONG-TERM DEPOSITS 53 119 172

PROPERTY AND EQUIPMENT -- net 128 620 490

INTANGIBLE ASSETS -- net 18 32 25

DEFERRED TAX ASSET -- -- 19

--------- --------- ---------

T o t a l assets 13,563 33,803 26,900

========= ========= =========

Liabilities and shareholders' equity

CURRENT LIABILITIES:

Accounts payable and accrued expenses 3,130 2,705 3,003

Deferred gain
'/>"/>

SOURCE XTL Biopharmaceuticals Ltd Copyright©2007 PR Newswire.

0 GOOD